Saturday, October 18, 2014: 3:45 PM-5:15 PM
LACC 507 (Los Angeles Convention Center)
Chair:
Rosalina James, PhD, Assistant Professor, University of Washington
Description: Pharmacogenetic testing (PGX) offers opportunities to increase efficacy of the tobacco cessation program however, little is known about barriers to PGX in Alaska Native/American Indian communities. To inform future programs, we conducted semi-structured interviews. The majority of stakeholders endorse the use of PGX to guide tobacco cessation in primary care.
4:10 PM
4:30 PM
See more of: Scientific Symposia Sessions